Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CA G1049R + AKT1 E17K
i
Other names:
AKT1, AKT, PKB, PRKBA, RAC, V-akt murine thymoma viral oncogene homolog 1, PIK3CA, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, Phosphoinositide-3-kinase, catalytic, alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit P110-alpha, PI3K-alpha, Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 KDa catalytic subunit alpha, Phosphatidylinositol 3-kinase, Catalytic, 110-KD, alpha, PI3-kinase P110 subunit alpha, PI3-kinase subunit alpha, PtdIns
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5290
;
207
Related biomarkers:
Expression
Mutation
CNA
Others
‹
PIK3CA amplification (12)
AKT1 amplification (1)
PIK3CA amplification (12)
AKT1 amplification (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CA G1049R + AKT1 E17K
Non Small Cell Lung Cancer
PIK3CA G1049R + AKT1 E17K
Non Small Cell Lung Cancer
trametinib + dabrafenib
Resistant: C3 – Early Trials
trametinib + dabrafenib
Resistant
:
C3
trametinib + dabrafenib
Resistant: C3 – Early Trials
trametinib + dabrafenib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.